Luci David P Insider Trades

Insider Trading History

Track insider trading activity for Luci David P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
President And CEO
Holding Value $65.7k 37,100 shares
Last Trade
Apr 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.6k 37,100 shares
$2.36
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $443k 250,000 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.99M 250,000 shares
$15.96
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $87.2k 49,261 shares
Last Trade
Jan 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.07M 49,261 shares
$21.80
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $1.94M 1,097,458 shares
Last Trade
Jan 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.07M 49,261 shares
$21.80
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $443k 250,000 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.8M 250,000 shares
$63.00
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $1.86M 1,048,197 shares
Last Trade
Jan 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.63M 19,737 shares
$82.40
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $0 0 shares
Last Trade
Jan 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.63M 19,737 shares
$82.40
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $230k 130,000 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.87M 130,000 shares
$68.20
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
President And CEO
Holding Value $34.9k 19,737 shares
Last Trade
Jul 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.46M 19,737 shares
$74.00
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $1.79M 1,008,723 shares
Last Trade
Nov 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$505k 5,200 shares
$97.20
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $885k 500,000 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.8M 500,000 shares
$123.60
$1.77
Acurx Pharmaceuticals
Acurx Pharmaceuticals ACXP
10% owner, President And CEO
Holding Value $620k 350,000 shares
Last Trade
Jun 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.8M 350,000 shares
$125.20
$1.77
Enveric Biosciences
Enveric Biosciences ENVB
Director
Holding Value $294k 150,000 shares
Last Trade
Aug 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9B 165,000 shares
$114,750.00
$1.96
Enveric Biosciences
Enveric Biosciences ENVB
Director
Holding Value $294k 150,000 shares
Last Trade
Aug 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9B 165,000 shares
$114,750.00
$1.96
Enveric Biosciences
Enveric Biosciences ENVB
Director
Holding Value $0 0 shares
Last Trade
Nov 17, 2017 Sale
$636M 2,430 shares
$261,750.00
$1.96
Enveric Biosciences
Enveric Biosciences ENVB
Director
Holding Value $0 0 shares
Last Trade
Nov 17, 2017 Sale
$636M 2,430 shares
$261,750.00
$1.96
PLx Pharma
PLx Pharma PLXP
Director
Holding Value $0 0 shares
Last Trade
Apr 19, 2017 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$400k 298,826 shares
$1.34
$0.09
PLx Pharma
PLx Pharma PLXP
Director
Holding Value $23.9k 275,000 shares
Last Trade
Jan 17, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$426k 275,000 shares
$1.55
$0.09
PLx Pharma
PLx Pharma PLXP
10% owner, President, Ceo, Secretary
Holding Value $3.05k 35,000 shares
Last Trade
Jan 19, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 35,000 shares
$8.91
$0.09
PLx Pharma
PLx Pharma PLXP
10% owner, President, Ceo, Secretary
Holding Value $29k 333,826 shares
Last Trade
Jan 05, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 35,000 shares
$13.10
$0.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up